Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSPAC-1: Surgery vs. Chemotherapy for Pancreatic Cancer with Liver Oligometastasis
NCT03398291Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Jul 2018
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pancreatic cancer (PC) and liver metastasis, sponsored by Fudan University. Primary endpoint: Real Overall Survival at 2 years. Status: unknown.
02
Conditions
pancreatic cancer (PC)liver metastasis
Beyond the preview
Go deeper on NCT03398291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398291.